The usefulness of long-acting calcium channel blocker for hypertensive patients with metabolic syndrome
Ishida, A.; Ohya, Y.
Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 1): 582-586
2011
ISSN/ISBN: 0047-1852 PMID: 21766664 Document Number: 653191
Document emailed within 1 workday
Related Documents
Takishita, S. 2006: Usefulness of long-acting Ca antagonist in hypertensive patients with metabolic syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 64(Suppl 9): 607-610Katayama, S. 2005: Clinical significance of calcium channel blocker in patients with metabolic syndrome Clinical Calcium 15(10): 1657-1662
Vacher, E.; Richer, C.; Fornes, P.; Clozel, J.P.; Giudicelli 1996: Mibefradil, a selective calcium T-channel blocker, in stroke-prone spontaneously hypertensive rats Journal of Cardiovascular Pharmacology 27(5): 686-694
Tsutamoto, T.; Tsutsui, T.; Maeda, K.; Hayashi, M.; Wada, A.; Ohnishi, M.; Fujii, M.; Ishii, C. 2003: Effects of long-acting calcium channel antagonists on neurohumoral factors: comparison of nifedipine coat-core with amlodipine Journal of Cardiovascular Pharmacology 41(Suppl 1): S77-S81
Takeuchi, T.; Hasebe, N. 2016: Calcium channel blocker Nihon Rinsho. Japanese Journal of Clinical Medicine 74 Suppl 4 Pt 1: 562-567
Liao, P.-A.; Pan, S.-W.; Chen, C.-Y.; Deng, C.-Y.; Dong, Y.-H. 2023: Prescription Patterns of new use of Fixed-Dose Combination Inhalers in Patients with Chronic Obstructive Pulmonary Disease: Long-Acting β2 Agonists Plus Long-Acting Muscarinic Antagonists versus Long-Acting β2 Agonists Plus Inhaled Corticosteroids International Journal of Chronic Obstructive Pulmonary Disease 18: 553-563
Lenfant, C. 1995: The calcium channel blocker scare. Lessons for the future Circulation 91(12): 2855-2856
Borghi, C. 2006: Hypertensive patients can benefit from a new generation of calcium channel blockers. Lercanidipine: effective with few side effects Revue Medicale Suisse 2(65): 1266-1267
Heaps, T. 2011: Problem-based review: calcium channel blocker (CCB) poisoning Acute Medicine 10(3): 153-155
Rohatgi, S.; Bhattacharya, R.; Das Gupta, S. 1993: Efficacy of calcium channel blocker as an adjunct in therapy of organophosphate poisoning Indian Journal of Physiology and Pharmacology 37(3): 255-256
Sun, Q.; Li, Q.-x.; Song, X.-f.; Zheng, S.-g.; Yan, F.; Chen, P.; Tang, J.-f.; Niu, Y.-x.; Bao, Q.-y.; Zhang, G.-q.; Hu, Y.-l. 2012: Impact of CACNA1C polymorphisms on antihypertensive efficacy of calcium channel blocker Zhonghua Xin Xue Guan Bing Za Zhi 40(1): 3-7
Casellas, N.; Ferrani, A.; Cutillas, B.; Mahy, N. 1990: Characterization of D2-dopamine receptor modification in rat striatum after calcium channel blocker treatment Methods and Findings in Experimental and Clinical Pharmacology 12(9): 609-611
Pamnani, M.B.; Haddy, F.J.; Bryant, H.J.; Swindall, B.T.; Hom, G.J.; Johnston, J.; Cragoe, E.J. 1986: Effects of 6-iodo-amiloride, a sodium channel blocker, on cardiovascular parameters in spontaneously hypertensive and Wistar-Kyoto rats Journal of Hypertension. Suppl: Official Journal of the International Society of Hypertension 4(3): S491-S493
Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. 1985: Cure of mice bearing P388 leukemia by vincristine in combination with a calcium channel blocker Cancer Treatment Reports 69(5): 523-525
Ennis, C.; Granger, S.E.; Middlefell, V.C.; Philpot, M.E.; Shepperson, N.B. 1989: Pharmacologic effects of Wy 27569: a combined calcium channel blocker and thromboxane synthetase inhibitor Journal of Cardiovascular Pharmacology 13(4): 511-519
Zarghi, A.; Faizi, M.; Abdolahnejad, R.; Fassihi, A. 2003: Synthesis and calcium channel blocker activity of alkyl 1,4-dihydro-2,6-dimethyl-4-nitrobenzyl thioimidazolyl-3,5-pyridinedicarboxylates Bollettino Chimico Farmaceutico 142(4): 175-179
Onuki, T. 1995: Effects of a calcium channel blocker, manidipine hydrochloride, on the regulatory mechanism of glomerular capillary pressure in SHR Nihon Jinzo Gakkai Shi 37(2): 119-126
Yu, Y.; Pan, C.; Ling, H.; Wu, W.; Xiao, G. 2014: Protection of T-type calcium channel blocker in spiral ganglion neurons of adult C57BL/6J mice Zhonghua Yi Xue Za Zhi 94(35): 2781-2785
Lawrence, D.B.; Weart, C.W.; Laro, J.J.; Neville, B.W. 1994: Calcium channel blocker-induced gingival hyperplasia: case report and review of this iatrogenic disease Journal of Family Practice 39(5): 483-488
Civera, C.; Vázquez, A.; Sevilla, J.M.; Bruix, M.; Gago, F.; García, A.G.; Sevilla, P. 1999: Solution structure determination by two-dimensional 1H NMR of omega-conotoxin MVIID, a calcium channel blocker peptide Biochemical and Biophysical Research Communications 254(1): 32-35